Download FREE Report Sample
Download Free sampleGlucagon is a metabolic hormone secreted by the pancreas that raises blood glucose levels by causing the liver to rapidly convert glycogen (the stored form of glucose) into glucose, which is then released into the bloodstream. Glucagon and insulin are two critical hormones in a glycemic control system that keeps blood glucose at the right level in healthy individual. Glucagon is a medicine which used to treat severe low blood sugar (hypoglycemia). Glucagon works by telling your body to release sugar (glucose) into the bloodstream to bring the blood sugar level back up.
Glucagon Market contains market size and forecasts of Glucagon in global, including the following market information:
Global Glucagon Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Glucagon Market Sales, 2017-2022, 2023-2028, (K MT)
Global top five Glucagon companies in 2021 (%)
The global Glucagon market was valued at 572.1 million in 2021 and is projected to reach US$ 851 million by 2028, at a CAGR of 5.8% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Inject Glucagon Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Glucagon include Novo Nordisk, Eli Lilly, Fresenius Kabi, Torrent Labs, Taj Pharmaceuticals and Xeris Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Glucagon manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Glucagon Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Glucagon Market Segment Percentages, by Type, 2021 (%)
Inject Glucagon
Nasal Glucagon
Global Glucagon Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Glucagon Market Segment Percentages, by Application, 2021 (%)
Emergency Kits
General Use
Diagnostic & Motility
Cardiogenic Shock
Others
Global Glucagon Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Glucagon Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Glucagon revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Glucagon revenues share in global market, 2021 (%)
Key companies Glucagon sales in global market, 2017-2022 (Estimated), (K MT)
Key companies Glucagon sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novo Nordisk
Eli Lilly
Fresenius Kabi
Torrent Labs
Taj Pharmaceuticals
Xeris Pharmaceuticals
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
